Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-16 · accession 0001849739-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-21 | 2026-01-16+ | IBRX | Selecky Christobel | Dir | M - OptEx | $2.98 | +75.0K | 50.0K | New | +$223.5K |
| DM | 2026-01-21 | 2026-01-16+ | IBRX | Selecky Christobel | Dir | S - Sale+OE | $5.84 | -75.0K | 0 | -100% | -$437.8K |
| DM | 2026-01-21 | 2026-01-16+ | IBRX | Selecky Christobel | Dir | M - OptEx | $0.00 | -75.0K | 92.9K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | M | A | 25,000 | $2.98 | 25,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-16 | M | A | 50,000 | $2.98 | 50,000 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-20 | S | D | 25,000 | $7.51 | 0 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 25,000 shares sold in the price range of $7.50 to $7.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-01-16 | S | D | 50,000 | $5.00 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2026-01-16 | M | D | 50,000 | $0.00 | 117,937 | D | $2.98 · — to 2032-06-14 | 50,000 Common Stock | (F3) One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders. |
| 6 | Derivative | Stock Option (right to buy) | 2026-01-20 | M | D | 25,000 | $0.00 | 92,937 | D | $2.98 · — to 2032-06-14 | 25,000 Common Stock | (F3) One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders. |